|
WO2011084479A1
|
|
Substance p and analogs thereof as adjuvant therapy for adoptive cellular immunotherapy
|
|
WO2011047287A1
|
|
Methods of treating inflammatory and fibrotic lung diseases with substance p analogs
|
|
WO2009129498A2
|
|
Substance p and analogs thereof as a cancer immunogenic composition adjuvant
|
|
WO2009085236A2
|
|
Compositions and methods of using substance p. analogs
|
|
WO2009017662A2
|
|
Method of using substance p analogs for treatment amelioration of myelodysplastic syndrome
|
|
EP2184996A2
|
|
Methods of treating blood cell depletion
|
|
AU2008282931A1
|
|
Methods and compositions for stimulating the proliferation or differentiation of stem cells with substance P or an analog thereof
|
|
US2009099092A1
|
|
Methods for stimulating fibroblast proliferation using substance p analogs
|
|
WO2008088846A2
|
|
Substance p and analogs thereof as an immunogenic composition adjuvant
|
|
WO2008036157A2
|
|
Prophylactic and therapeutic treatment of avian influenza infections in animals
|
|
US2010062986A1
|
|
Method to treat blood cell depletion
|
|
WO2008054465A2
|
|
Method to reduce the risk and/or severity of anthrax infection
|
|
WO2006076119A2
|
|
Treatment of skin diseases
|
|
AU2005299341A1
|
|
Method to promote wound healing
|
|
SG126014A1
|
|
Treatment of asthma
|
|
US2008193403A1
|
|
Inducing And Maintaining Hair Color
|
|
SG123646A1
|
|
Prevention of respiratory infections in fowl
|
|
SG124310A1
|
|
Treatment of skin diseases
|
|
EP1613337A1
|
|
Acute respiratory syndromes
|
